Llwytho...
NSD2 Promotes Renal Cancer Progression Through Stimulating Akt/Erk Signaling
BACKGROUND: Nuclear receptor suppressor of variegation, enhancer of zeste, and trithorax (SET) domain-containing 2 (NSD2), is a well-known histone lysine methyltransferase (HMTase). The aim of this study was to investigate the biological role of NSD2 in clear cell renal cell carcinoma (ccRCC). METHO...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cancer Manag Res |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6974414/ https://ncbi.nlm.nih.gov/pubmed/32021450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S222673 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|